Melanoma Focus Virtual Regional Meeting
Friday 13th May 2022
Organised by Dr Miranda Payne
Registration for this event is now open
The Melanoma Focus virtual meeting May 2022 has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 6 category 1 (external) CPD credit(s).
The Royal College of Surgeons of England has awarded up to 5.25 CPD points and the British Association of Plastic, Reconstructive and Aesthetic Surgeons has awarded up to 8.5 CME credits
2022 Registration Fees:
Member Rates
Earlybird (ends 17/04/22) | Late registration | ||
---|---|---|---|
Consultant | Open Form | £89 | £109 |
Other Clinician/AHP | Open Form | £69 | £79 |
Nurse/medical student | Open Form | £25 | £35 |
Non-Member Rates
Earlybird (ends 17/04/22) | Late registration | ||
---|---|---|---|
Consultant | Open Form | £129 | £149 |
Other Clinician/AHP | Open Form | £85 | £99 |
Nurse/medical student | Open Form | £45 | £55 |
Industry | Open Form | £169 | £169 |
Programme
09:00 - 09:15 | Welcome/Introductions |
09:15 - 10:00 | Stage II Melanoma: Developments as a result from advances in systemic therapies Associate Professor Alexander van Akkooi, Chair of Melanoma Surgery, Melanoma Institute of Australia |
09:15 – 12:30 | Pharma Exhibition Area / Posters |
10:10 – 10:50 | Virtual Networking: |
11:00 – 12:00 | Pharma Sponsored Symposium: Novartis Survivorship – A new treatment goal for advanced melanoma? |
12:30 – 13:35 | Session 1: Molecular surveillance of melanoma |
12:30 – 12:55 | Circulating tumour DNA; a new tool for the clinic |
12:55 – 13:20 | Biofluid metabolomics – the other liquid biopsy for cancer detection |
13:20 – 13:35 | Q&A |
13:35 – 14:35 | Session 2: Living beyond a stage 4 diagnosis |
13:35 – 14:15 | Caroline Kohl (10 mins), Paul Duhig (10 mins), Dr Shelley Petzer (10 mins) |
14:15 – 14:35 | Q&A |
14:35 – 14:45 | Comfort Break |
14:45 – 16:30 | Session 3: Practice changes in oncology Chair: Dr Ben Fairfax, Wellcome Intermediate Clinical Fellow and Honorary Consultant Medical Oncologist |
14:45 – 15:10 | Using Artificial Intelligence approaches to address an unmet need for melanoma |
15:10 – 15:35 | Findings from the first UK Census of Skin Cancer Specialist Nurses |
15:35 – 16:15 | Melanoma immunotherapy: response and toxicity |
16:15 – 16:30 | Q&A |
16:30 – 17:25 | Session 4: MDT – Management of progression on adjuvant treatment (case-based discussions) |
17:25 – 17:30 | Concluding Remarks and Close |